New diabetes clinical trial: Prospective Longitudinal Observational Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.

Published on: 2026-03-13T04:00:00Z
Conditions: Insulin-dependent Diabetes (Type 1 Diabetes, Secondary to Chronic Pancreatitis, MODY, Cystic Fibrosis)
Interventions: Other: Continuous glucose monitoring (CGM) with TITR measurement
Sponsors: University Hospital, Strasbourg, France
Recruiting
https://ift.tt/b0KZpWV

Comments